GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

The journal’s editorial board includes multiple scientists, such as Trump health nominees Jay Bhattacharya and Marty Makary, ...

The results are detailed in a study published January 30 in the New England Journal of Medicine. TB is a bacterial infection that primarily affects the lungs. It spreads through air droplets ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed ... University School of Medicine in St. Louis and the ...

GLP-1 receptor agonist medications like Ozempic may do more than just change your ... Meet the experts: Dina Peralta-Reich, MD, is an obesity medicine specialist and founder of New York Weight ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

When a GLP-1 drug similar to Ozempic helped slow Parkinson's symptoms A recent New England Journal of Medicine study tested lixisenatide, a GLP-1 drug, as a potential treatment for early-stage ...

A comprehensive new study confirmed that GLP-1 medications such as Ozempic and Mounjaro have ... Published in the journal Nature Medicine, the research examined the relationship between GLP ...

weekly injections of blockbuster drugs such as Novo Nordisk’s Ozempic and Wegovy could slash the risk of severe outcomes, a study published in the New England Journal of Medicine on Friday finds.

Will the Super Bowl Ads Be Woke? Consequences for the International Criminal Court The International Criminal Court Has Put Itself at Trump’s Mercy Tinker, Tailor, Soldier, German Chancellor ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...